TUESDAY, Nov. 25, 2025 — A pill version of semaglutide, the ingredient in Ozempic and Wegovy, did not slow the progress of Alzheimer’s disease, drugmaker Novo Nordisk announced Monday.
In two Phase 3 trials, researchers tested an oral…
Blog
Leave a Reply